Academic · Private company
University of Sydney
Track this companyFree. Adds University of Sydney to your Dealase workspace and tells you when its record changes.
Clinical trials76 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIALNA · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07532070 · fetched Nov 12, 2026
- Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstatePHASE3 · ACTIVE_NOT_RECRUITING · started Mar 31, 2020ClinicalTrials.gov NCT04136353 · fetched Nov 12, 2026
- Observational Study of Cardiovascular Disease.TERMINATED · started Feb 5, 2020ClinicalTrials.gov NCT04128475 · fetched Nov 12, 2026
- Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBMPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 22, 2018ClinicalTrials.gov NCT04195139 · fetched Nov 12, 2026
- Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 1, 2014ClinicalTrials.gov NCT02446444 · fetched Nov 12, 2026
- Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 1, 2014ClinicalTrials.gov NCT02446405 · fetched Nov 12, 2026
- Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursPHASE3 · RECRUITING · started Feb 1, 2014ClinicalTrials.gov NCT02582697 · fetched Nov 12, 2026